Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
In: Emerging Infectious Diseases, Jg. 30 (2024), Heft 4, S. 775-778
Online
academicJournal
Zugriff:
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
Titel: |
Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
|
---|---|
Autor/in / Beteiligte Person: | Tobolowsky, Farrell A. ; Nsubuga, Fred ; Gilani, Zunera ; Kisakye, Annet ; Ndagije, Helen ; Kyabayinze, Daniel ; Gidudu, Jane F. |
Link: | |
Zeitschrift: | Emerging Infectious Diseases, Jg. 30 (2024), Heft 4, S. 775-778 |
Veröffentlichung: | Centers for Disease Control and Prevention, 2024 |
Medientyp: | academicJournal |
ISSN: | 1080-6040 (print) ; 1080-6059 (print) |
DOI: | 10.3201/eid3004.231361 |
Schlagwort: |
|
Sonstiges: |
|